Towards Next Generation Bifunctional Cancer Antibodies: A Collaboration Between Bilkent University UNAM and Nobel Pharmaceuticals

Towards Next Generation Bifunctional Cancer Antibodies: A Collaboration Between Bilkent University UNAM and Nobel Pharmaceuticals

Towards Next Generation Bifunctional Cancer Antibodies: A Collaboration Between Bilkent University UNAM and Nobel Pharmaceuticals Bilkent UNAM and Nobel Pharmaceutical are stakeholders in an ongoing cancer antibody research and development project which is currently supported through TUBITAK 1003 priority areas research program. The aim of the project is to develop new generation of bifunctional antibodies [...]